Literature DB >> 31232663

[Hereditary Colorectal Cancer: Clinics, Diagnostics and Management].

Karl Heinimann1.   

Abstract

Hereditary Colorectal Cancer: Clinics, Diagnostics and Management Abstract. About five percent of all colorectal cancers are caused by highly penetrant, autosomal dominantly or recessively inherited tumour predispositions. Current molecular genetic diagnostics, making use of high-throughput sequencing technologies, allow a cost-efficient, prompt and comprehensive investigation. In contrast to sporadic colorectal cancer hereditary forms are often associated with an elevated lifetime risk for additional, extracolonic tumours which necessitate specific long-term interdisciplinary prevention measures and surveillance. Moreover, the genetic confirmation of an underlying cancer predisposition allows family members at risk, following genetic counselling, the possibility of predictive carrier testing. This article aims at providing a concise overview of clinics, diagnostics and management for some of the best researched colorectal cancer predispositions.

Entities:  

Mesh:

Year:  2018        PMID: 31232663     DOI: 10.1024/0040-5930/a001046

Source DB:  PubMed          Journal:  Ther Umsch        ISSN: 0040-5930


  9 in total

1.  A bayesian approach to model the underlying predictors of early recurrence and postoperative death in patients with colorectal Cancer.

Authors:  Leila Mahmoudi; Ramezan Fallah; Ghodratollah Roshanaei; Mohammad Asghari-Jafarabadi
Journal:  BMC Med Res Methodol       Date:  2022-10-12       Impact factor: 4.612

Review 2.  Chemical Compounds of Berry-Derived Polyphenols and Their Effects on Gut Microbiota, Inflammation, and Cancer.

Authors:  Abdelhakim Bouyahya; Nasreddine El Omari; Naoufal El Hachlafi; Meryem El Jemly; Maryam Hakkour; Abdelaali Balahbib; Naoual El Menyiy; Saad Bakrim; Hanae Naceiri Mrabti; Aya Khouchlaa; Mohamad Fawzi Mahomoodally; Michelina Catauro; Domenico Montesano; Gokhan Zengin
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

3.  Influence of Early Predictive Nursing on Complications and Quality of Life in Patients after Colorectal Cancer Surgery.

Authors:  Jing Gao; Qiuyang Zhang; Xiaolin Zhao; Wei Gao
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

4.  Application of Bevacizumab Combined With Chemotherapy in Patients With Colorectal Cancer and Its Effects on Brain-Gut Peptides, Intestinal Flora, and Oxidative Stress.

Authors:  Chao Chen; Songtao Hou; Fei Zhao; Bin Wu; Tingting Liu; Zhao Zhang; Yuwei Li; Hongchao Li
Journal:  Front Surg       Date:  2022-04-11

5.  Hyal1 Expression in Colorectal Carcinoma Cell Migration and Invasiveness: Significance and Mechanism.

Authors:  Shuangshuang Zhao; Junhui Zhao; Ni Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-05       Impact factor: 2.650

6.  Construction of Nomogram-Based Prediction Model for Clinical Prognosis of Patients with Stage II and III Colon Cancer Who Underwent Xelox Chemotherapy after Laparoscopic Radical Resection.

Authors:  Qiang Sun; Kai Xu; Shifeng Teng; Wenqiang Wang; Wei Zhang; Xinxing Li; Zhiqian Hu
Journal:  J Oncol       Date:  2022-09-30       Impact factor: 4.501

7.  COPB2 gene silencing inhibits colorectal cancer cell proliferation and induces apoptosis via the JNK/c-Jun signaling pathway.

Authors:  Yan Wang; Guangmei Xie; Min Li; Juan Du; Min Wang
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

8.  Mechanism of Gegen Qinlian Decoction Regulating ABTB1 Expression in Colorectal Cancer Metastasis Based on PI3K/AKT/FOXO1 Pathway.

Authors:  Feng Li; Lili Chen; Jinzhou Zheng; Jianfeng Yang; Xiaoyun Song; Yu Wang; Xiqiu Zhou
Journal:  Biomed Res Int       Date:  2022-01-24       Impact factor: 3.411

9.  The Clinical Value of the Combined Detection of Enhanced CT, MRI, CEA, and CA199 in the Diagnosis of Rectal Cancer.

Authors:  Cuijuan Hao; Yanbin Sui; Jian Li; Yunxia Shi; Zhenxing Zou
Journal:  J Oncol       Date:  2021-07-13       Impact factor: 4.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.